Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 13Breast Neoplasms 4Neoplasms 3Sexual Dysfunction, Physiological 2Pulmonary Disease, Chronic Obstructive 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 2Overweight 2Endometrial Neoplasms 2Dyspnea 2Constipation 2Colorectal Neoplasms 2Weight Loss 1Vomiting 1Uterine Cervical Neoplasms 1Syndrome 1Sexual Dysfunctions, Psychological 1Pediatric Obesity 1Pain 1Osteoporosis 1Nausea 1Mucositis 1Motor Activity 1Metabolic Diseases 1Lung Neoplasms 1Lung Diseases, Interstitial 1Li-Fraumeni Syndrome 1Leukemia 1Intermittent Fasting 1Inflammatory Breast Neoplasms 1

Interventions

naldemedine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nausea × Other × 30 days × Clear all
NCT07038551 2026-06-03

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

International University of Health and Welfare

Phase 4 Completed
120 enrolled
Other

Constipation, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡